SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-226123
Filing Date
2022-08-22
Accepted
2022-08-22 09:30:40
Documents
12
Period of Report
2022-08-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d233621d8k.htm   iXBRL 8-K 33936
  Complete submission text file 0001193125-22-226123.txt   156950

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20220819.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20220819_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20220819_pre.xml EX-101.PRE 11256
6 EXTRACTED XBRL INSTANCE DOCUMENT d233621d8k_htm.xml XML 3348
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 221182424
SIC: 2834 Pharmaceutical Preparations